{"title":"循环性死亡后捐献胰腺移植","authors":"Jeffery Campsen, Michael A. Zimmerman","doi":"10.1016/j.tpr.2022.100120","DOIUrl":null,"url":null,"abstract":"<div><p>Diabetes mellitus is a major cause of morbidity and mortality worldwide. Pancreas transplantation has evolved into a viable treatment option in this patient population. While the majority of procedures are performed as either simultaneous pancreas-kidney (SPK) or pancreas after kidney (PAK), the resulting glycemic control leads to a significant delay in the progression of cardiovascular disease. At present, there is a critical organ shortage. Donation after circulatory death (DCD) may be a strategy to increase the pancreas donor pool. Herein, we examine the clinical parameters that impact organ selection and review the current experience with pancreas transplantation in the setting of DCD donation.</p></div>","PeriodicalId":37786,"journal":{"name":"Transplantation Reports","volume":"7 4","pages":"Article 100120"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2451959622000282/pdfft?md5=5cc3b2bbd8c1f6a90cf3240af4540fe7&pid=1-s2.0-S2451959622000282-main.pdf","citationCount":"1","resultStr":"{\"title\":\"Pancreas transplantation following donation after circulatory death\",\"authors\":\"Jeffery Campsen, Michael A. Zimmerman\",\"doi\":\"10.1016/j.tpr.2022.100120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Diabetes mellitus is a major cause of morbidity and mortality worldwide. Pancreas transplantation has evolved into a viable treatment option in this patient population. While the majority of procedures are performed as either simultaneous pancreas-kidney (SPK) or pancreas after kidney (PAK), the resulting glycemic control leads to a significant delay in the progression of cardiovascular disease. At present, there is a critical organ shortage. Donation after circulatory death (DCD) may be a strategy to increase the pancreas donor pool. Herein, we examine the clinical parameters that impact organ selection and review the current experience with pancreas transplantation in the setting of DCD donation.</p></div>\",\"PeriodicalId\":37786,\"journal\":{\"name\":\"Transplantation Reports\",\"volume\":\"7 4\",\"pages\":\"Article 100120\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2451959622000282/pdfft?md5=5cc3b2bbd8c1f6a90cf3240af4540fe7&pid=1-s2.0-S2451959622000282-main.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2451959622000282\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451959622000282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Pancreas transplantation following donation after circulatory death
Diabetes mellitus is a major cause of morbidity and mortality worldwide. Pancreas transplantation has evolved into a viable treatment option in this patient population. While the majority of procedures are performed as either simultaneous pancreas-kidney (SPK) or pancreas after kidney (PAK), the resulting glycemic control leads to a significant delay in the progression of cardiovascular disease. At present, there is a critical organ shortage. Donation after circulatory death (DCD) may be a strategy to increase the pancreas donor pool. Herein, we examine the clinical parameters that impact organ selection and review the current experience with pancreas transplantation in the setting of DCD donation.
期刊介绍:
To provide to national and regional audiences experiences unique to them or confirming of broader concepts originating in large controlled trials. All aspects of organ, tissue and cell transplantation clinically and experimentally. Transplantation Reports will provide in-depth representation of emerging preclinical, impactful and clinical experiences. -Original basic or clinical science articles that represent initial limited experiences as preliminary reports. -Clinical trials of therapies previously well documented in large trials but now tested in limited, special, ethnic or clinically unique patient populations. -Case studies that confirm prior reports but have occurred in patients displaying unique clinical characteristics such as ethnicities or rarely associated co-morbidities. Transplantation Reports offers these benefits: -Fast and fair peer review -Rapid, article-based publication -Unrivalled visibility and exposure for your research -Immediate, free and permanent access to your paper on Science Direct -Immediately citable using the article DOI